Diabetes Treatments

Incretin Drugs Semaglutide Weight-loss Drugs Mounjaro Ozempic

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

The pharmaceutical giant saw strong demand for its diabetes and weight-loss drugs but missed revenue estimates due to lower realized prices and inventory issues.

3 ARTICLES

5mo ago

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

8 ARTICLES

last yr.

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

4 ARTICLES

last yr.

Drugmakers Raise Prices for Over 700 Medications, Including Popular Weight-Loss Drugs Ozempic and Mounjaro